• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进一步描述 L-DOPA 诱导 MPTP 损毁恒河猴出现类精神病行为。

Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset.

机构信息

Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, QC, H3A 2B4, Canada.

Comparative Medicine & Animal Resource Centre, McGill University, Montreal, QC, Canada.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2021 Aug;394(8):1685-1692. doi: 10.1007/s00210-021-02090-6. Epub 2021 May 8.

DOI:10.1007/s00210-021-02090-6
PMID:33963876
Abstract

Parkinson's disease (PD) psychosis afflicts over half of patients and poses a significant burden on quality of life. The aetiology of PD psychosis is multifactorial and likely arises from the complex interaction between dopamine replacement therapy and disease state. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned common marmoset is a validated model to predict the efficacy of therapeutic compounds for treatment-related complications, including PD psychosis. In this model, psychosis-like behaviours (PLBs) encompass stereotypies that are idiosyncratic in nature and reproducible with each L-3,4-dihydroxyphenylanaline (L-DOPA) administration. In the present study, we sought to expand upon the existing repertoire of PLBs through the characterisation of novel stereotypical behaviours that appear dependent on the environment. We then discuss our findings in the context of clinical reports on stereotypical behaviours termed "punding" in subjects with PD, which consists of stereotypical repetitive and senseless behaviours. The poor understanding of the pathophysiology governing punding and consequent lack of effective therapies stand to benefit from enhanced characterisation of these stereotypical behaviours in a validated pre-clinical model. We hope that further characterisation of PLBs in the MPTP-lesioned marmoset will be helpful in the evaluation of interventions that seek to alleviate PD psychosis symptoms.

摘要

帕金森病(PD)精神病影响超过一半的患者,并对生活质量造成重大负担。PD 精神病的病因是多因素的,可能是由于多巴胺替代疗法和疾病状态之间的复杂相互作用引起的。1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)损伤的普通狨猴是一种经过验证的模型,可以预测治疗相关化合物治疗相关并发症的疗效,包括 PD 精神病。在该模型中,类精神病行为(PLB)包括刻板行为,这些行为具有独特的性质,可以通过每次 L-3,4-二羟基苯丙氨酸(L-DOPA)给药来重现。在本研究中,我们试图通过描述新的刻板行为来扩展现有的 PLB 谱,这些行为似乎依赖于环境。然后,我们根据临床报告中关于刻板行为的发现进行讨论,这些行为在 PD 患者中被称为“冲动行为”,包括刻板的重复和无意义的行为。由于对管理冲动行为的病理生理学的理解不足,以及缺乏有效的治疗方法,因此需要从经过验证的临床前模型中对这些刻板行为进行更深入的描述,以从中受益。我们希望进一步描述 MPTP 损伤的狨猴中的 PLB 将有助于评估旨在缓解 PD 精神病症状的干预措施。

相似文献

1
Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset.进一步描述 L-DOPA 诱导 MPTP 损毁恒河猴出现类精神病行为。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Aug;394(8):1685-1692. doi: 10.1007/s00210-021-02090-6. Epub 2021 May 8.
2
Additive effects of mGluR positive allosteric modulation, mGluR orthosteric stimulation and 5-HTR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.在 MPTP 损伤的狨猴中,代谢型谷氨酸受体正变构调节、代谢型谷氨酸受体变构刺激和 5-羟色胺受体拮抗作用对运动障碍和类精神病行为的相加作用。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Dec;394(12):2381-2388. doi: 10.1007/s00210-021-02162-7. Epub 2021 Sep 22.
3
Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset.吗氯贝胺抑制单胺氧化酶 A 增强 MPTP 损毁恒河猴模型中 L-DOPA 的抗帕金森作用。
Naunyn Schmiedebergs Arch Pharmacol. 2020 Nov;393(11):2157-2164. doi: 10.1007/s00210-020-01933-y. Epub 2020 Jul 3.
4
Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.甘氨酸转运体 1 抑制剂 ALX-5407 对 MPTP 损毁恒河猴运动障碍、类精神病行为和帕金森病的影响。
Eur J Pharmacol. 2021 Nov 5;910:174452. doi: 10.1016/j.ejphar.2021.174452. Epub 2021 Sep 1.
5
Effect of the mGlu positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.mGlu 正变构调节剂 CBiPES 对 MPTP 损毁恒河猴运动障碍、类精神病行为和帕金森病的影响。
J Neural Transm (Vienna). 2021 Jan;128(1):73-81. doi: 10.1007/s00702-020-02287-8. Epub 2021 Jan 3.
6
The mGluR orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.mGluR 正构激动剂 LY-404,039 可减少 MPTP 损毁恒河猴的运动障碍、类精神病行为和帕金森病。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Oct;396(10):2347-2355. doi: 10.1007/s00210-023-02587-2. Epub 2023 Jul 6.
7
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.米氮平对帕金森病狨猴多巴胺能精神病和运动障碍的影响。
Psychopharmacology (Berl). 2017 Mar;234(6):905-911. doi: 10.1007/s00213-017-4530-z. Epub 2017 Jan 27.
8
Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease.曲唑酮可缓解帕金森病猴模型的运动障碍和精神症状。
J Neural Transm (Vienna). 2018 Sep;125(9):1355-1360. doi: 10.1007/s00702-017-1830-8. Epub 2017 Dec 15.
9
Effect of the mGlu positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset.mGlu 正变构调节剂 ADX-88178 对 MPTP 损毁恒河猴帕金森病、类精神病行为和运动障碍的影响。
Psychopharmacology (Berl). 2023 Oct;240(10):2093-2099. doi: 10.1007/s00213-023-06428-1. Epub 2023 Jul 29.
10
5-HT blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review.5-羟色胺(5-HT)阻断治疗帕金森病的运动障碍和精神病:这种方法的疗效是否存在局限性?对MPTP损伤狨猴的一项研究及文献综述
Exp Brain Res. 2019 Feb;237(2):435-442. doi: 10.1007/s00221-018-5434-9. Epub 2018 Nov 15.

引用本文的文献

1
The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson's disease.在帕金森病双侧大鼠模型中,血清素投射通路的化学遗传靶向对左旋多巴诱导的运动障碍和精神病的影响。
Front Neural Circuits. 2024 Nov 14;18:1463941. doi: 10.3389/fncir.2024.1463941. eCollection 2024.
2
Positive allosteric mGluR modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.BINA 通过正变构调节 mGluR,可减轻 MPTP 损毁恒河猴的运动障碍和精神病样行为。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8917-8924. doi: 10.1007/s00210-024-03215-3. Epub 2024 Jun 11.
3

本文引用的文献

1
Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist.帕金森病患者的冲动控制症状:多巴胺激动剂的影响。
Parkinsonism Relat Disord. 2019 Nov;68:17-21. doi: 10.1016/j.parkreldis.2019.06.019. Epub 2019 Jun 26.
2
Activation of mGlu receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism.mGlu 受体的激活:一种缓解帕金森病实验模型中运动障碍和精神症状的新疗法。
Neuropharmacology. 2019 Nov 1;158:107725. doi: 10.1016/j.neuropharm.2019.107725. Epub 2019 Jul 25.
3
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.
Effect of the mGlu positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset.
mGlu 正变构调节剂 ADX-88178 对 MPTP 损毁恒河猴帕金森病、类精神病行为和运动障碍的影响。
Psychopharmacology (Berl). 2023 Oct;240(10):2093-2099. doi: 10.1007/s00213-023-06428-1. Epub 2023 Jul 29.
4
Punding in Parkinson's Disease: An Update.帕金森病中的刻板动作:最新进展
Mov Disord Clin Pract. 2023 Apr 23;10(7):1035-1047. doi: 10.1002/mdc3.13748. eCollection 2023 Jul.
帕金森病非运动症状治疗的研究进展——基于循证医学的评价
Mov Disord. 2019 Feb;34(2):180-198. doi: 10.1002/mds.27602. Epub 2019 Jan 17.
4
5-HT blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review.5-羟色胺(5-HT)阻断治疗帕金森病的运动障碍和精神病:这种方法的疗效是否存在局限性?对MPTP损伤狨猴的一项研究及文献综述
Exp Brain Res. 2019 Feb;237(2):435-442. doi: 10.1007/s00221-018-5434-9. Epub 2018 Nov 15.
5
Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset.奈法唑酮可减少帕金森猴的运动障碍,但不能减少类精神病行为。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Dec;391(12):1339-1345. doi: 10.1007/s00210-018-1549-6. Epub 2018 Aug 7.
6
Predictive Value of Parkinsonian Primates in Pharmacologic Studies: A Comparison between the Macaque, Marmoset, and Squirrel Monkey.灵长类动物在药理学研究中的预测价值:猕猴、狨猴和松鼠猴的比较。
J Pharmacol Exp Ther. 2018 May;365(2):379-397. doi: 10.1124/jpet.117.247171. Epub 2018 Mar 9.
7
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.米氮平对帕金森病狨猴多巴胺能精神病和运动障碍的影响。
Psychopharmacology (Berl). 2017 Mar;234(6):905-911. doi: 10.1007/s00213-017-4530-z. Epub 2017 Jan 27.
8
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.非痴呆帕金森病患者的刻板行为:与精神和成瘾谱系共病的关系。
J Neurol Sci. 2016 Mar 15;362:344-7. doi: 10.1016/j.jns.2016.02.016. Epub 2016 Feb 8.
9
Behavioral effects of levodopa.左旋多巴的行为效应。
Mov Disord. 2015 Jan;30(1):90-102. doi: 10.1002/mds.26121. Epub 2014 Dec 9.
10
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.多巴胺激动剂治疗帕金森病患者的冲动控制障碍:一项多中心研究。
J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):840-4. doi: 10.1136/jnnp-2013-306787. Epub 2014 Jan 16.